Growth Metrics

Axsome Therapeutics (AXSM) Amortization - Intangibles: 2022-2025

Historic Amortization - Intangibles for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to $1.6 million.

  • Axsome Therapeutics' Amortization - Intangibles rose 0.06% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year decrease of 0.27%. This contributed to the annual value of $6.4 million for FY2024, which is 0.27% up from last year.
  • Latest data reveals that Axsome Therapeutics reported Amortization - Intangibles of $1.6 million as of Q3 2025, which was up 1.13% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Axsome Therapeutics' Amortization - Intangibles peaked at $1.6 million during Q3 2022, and registered a low of $1.6 million during Q1 2025.
  • Over the past 3 years, Axsome Therapeutics' median Amortization - Intangibles value was $1.6 million (recorded in 2023), while the average stood at $1.6 million.
  • In the last 5 years, Axsome Therapeutics' Amortization - Intangibles climbed by 0.06% in 2024 and then dropped by 1.07% in 2025.
  • Axsome Therapeutics' Amortization - Intangibles (Quarterly) stood at $1.6 million in 2022, then remained steady at $1.6 million in 2023, then remained steady at $1.6 million in 2024, then increased by 0.06% to $1.6 million in 2025.
  • Its Amortization - Intangibles stands at $1.6 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.6 million for Q1 2025.